Indication
Clostridium perfringens empyema
*Clostridium perfringens* empyema is a rare, severe pleuropulmonary infection characterized by the accumulation of purulent, exudative fluid within the pleural cavity caused by the anaerobic, spore-forming bacillus *Clostridium perfringens*. Read more about Clostridium perfringens empyema
36 drugs 24 manufacturers
Drugs that treat it
Common Clostridium perfringens empyema therapies.
PENICILLIN G POTASSIUM
PFIZERPEN-G (penicillin G potassium)
PFIZERPEN-G (penicillin G potassium)
PENICILLIN G POTASSIUM
CLINDAMYCIN PHOSPHATE-D5W (clindamycin phosphate/dextrose 5 % in water)
PENICILLIN G POTASSIUM
CLINDAMYCIN PHOSPHATE-D5W (clindamycin phosphate/dextrose 5 % in water)
CLINDAMYCIN PHOSPHATE-D5W (clindamycin phosphate/dextrose 5 % in water)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon*Clostridium perfringens* empyema is a rare, severe pleuropulmonary infection characterized by the accumulation of purulent, exudative fluid within the pleural cavity caused by the anaerobic, spore-forming bacillus *Clostridium perfringens*.
It primarily affects the respiratory and pleural systems, occurring most frequently in adults with underlying vulnerabilities such as thoracic trauma, recent invasive thoracic or abdominal surgery, oropharyngeal aspiration, or transdiaphragmatic and hematogenous translocation from a gastrointestinal source.
Pathophysiologically, the organism proliferates in hypoxic pleural tissue and elaborates destructive exotoxins that drive tissue necrosis, prominent neutrophil infiltration, and rapid gas production, often leading to loculated effusions, hydropneumothorax, and severe systemic toxicity.
- gbmc.org
*Clostridium perfringens* empyema is a rare, severe pleuropulmonary infection characterized by the accumulation of purulent, exudative fluid within the pleural cavity caused by the anaerobic, spore-forming bacillus *Clostridium perfringens* It primarily affects the respiratory and pleural systems, occurring most frequently in adults with underlying vulnerabilities such as thoracic trauma, recent invasive thoracic or abdominal surgery, oropharyngeal aspiration, or transdiaphragmatic and hematogen...
- nih.gov
*Clostridium perfringens* empyema is a rare, severe pleuropulmonary infection characterized by the accumulation of purulent, exudative fluid within the pleural cavity caused by the anaerobic, spore-forming bacillus *Clostridium perfringens* Pathophysiologically, the organism proliferates in hypoxic pleural tissue and elaborates destructive exotoxins that drive tissue necrosis, prominent neutrophil infiltration, and rapid gas production, often leading to loculated effusions, hydropneumothorax, an...
- nih.gov
It primarily affects the respiratory and pleural systems, occurring most frequently in adults with underlying vulnerabilities such as thoracic trauma, recent invasive thoracic or abdominal surgery, oropharyngeal aspiration, or transdiaphragmatic and hematogenous translocation from a gastrointestinal source
- bmj.com
It primarily affects the respiratory and pleural systems, occurring most frequently in adults with underlying vulnerabilities such as thoracic trauma, recent invasive thoracic or abdominal surgery, oropharyngeal aspiration, or transdiaphragmatic and hematogenous translocation from a gastrointestinal source
- shmabstracts.org
It primarily affects the respiratory and pleural systems, occurring most frequently in adults with underlying vulnerabilities such as thoracic trauma, recent invasive thoracic or abdominal surgery, oropharyngeal aspiration, or transdiaphragmatic and hematogenous translocation from a gastrointestinal source Pathophysiologically, the organism proliferates in hypoxic pleural tissue and elaborates destructive exotoxins that drive tissue necrosis, prominent neutrophil infiltration, and rapid gas prod...
- nih.gov
It primarily affects the respiratory and pleural systems, occurring most frequently in adults with underlying vulnerabilities such as thoracic trauma, recent invasive thoracic or abdominal surgery, oropharyngeal aspiration, or transdiaphragmatic and hematogenous translocation from a gastrointestinal source
- nih.gov
Pathophysiologically, the organism proliferates in hypoxic pleural tissue and elaborates destructive exotoxins that drive tissue necrosis, prominent neutrophil infiltration, and rapid gas production, often leading to loculated effusions, hydropneumothorax, and severe systemic toxicity
Personalize your experience
Follow Clostridium perfringens empyema and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.